These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8373998)

  • 1. HIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies: a review.
    Malamud D; Friedman HM
    Crit Rev Oral Biol Med; 1993; 4(3-4):461-6. PubMed ID: 8373998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva and salivary gland alterations in HIV infection: a review.
    Matee MI; Simon E
    Afr Dent J; 1995; 9():25-9. PubMed ID: 9590897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the oral environment in HIV-1 transmission.
    Shugars DC; Wahl SM
    J Am Dent Assoc; 1998 Jul; 129(7):851-8. PubMed ID: 9685760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of HIV-1 infectivity by human salivas.
    Archibald DW; Cole GA
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1425-32. PubMed ID: 2078420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral transmission of HIV, reality or fiction? An update.
    Campo J; Perea MA; del Romero J; Cano J; Hernando V; Bascones A
    Oral Dis; 2006 May; 12(3):219-28. PubMed ID: 16700731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous salivary inhibitors of human immunodeficiency virus.
    Shugars DC; Alexander AL; Fu K; Freel SA
    Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
    Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
    Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified ELISA and western blot accurately determine anti-human immunodeficiency virus type 1 antibodies in oral fluids obtained with a special collecting device.
    Emmons WW; Paparello SF; Decker CF; Sheffield JM; Lowe-Bey FH
    J Infect Dis; 1995 Jun; 171(6):1406-10. PubMed ID: 7769274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of herpes simplex virus type 1 replication by human salivary secretions.
    Bergey EJ; Gu M; Collins AR; Bradway SD; Levine MJ
    Oral Microbiol Immunol; 1993 Apr; 8(2):89-93. PubMed ID: 8395041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland involvement in HIV-1 infection.
    Fox PC
    Oral Surg Oral Med Oral Pathol; 1992 Feb; 73(2):168-70. PubMed ID: 1549311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva and inhibition of HIV-1 infection: molecular mechanisms.
    Shugars DC; Sweet SP; Malamud D; Kazmi SH; Page-Shafer K; Challacombe SJ
    Oral Dis; 2002; 8 Suppl 2():169-75. PubMed ID: 12164652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluid tests for screening of human immunodeficiency virus-exposed infants.
    Sherman GG; Lilian RR; Coovadia AH
    Pediatr Infect Dis J; 2010 Feb; 29(2):169-72. PubMed ID: 19907360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anti-HIV antibodies in saliva.
    Urquia M; Rodriguez-Archilla A; Gonzalez-Moles MA; Ceballos A
    J Oral Pathol Med; 1993 Apr; 22(4):153-6. PubMed ID: 8315593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (C2) Saliva, breast milk, and mucosal fluids in HIV transmission.
    Page-Shafer K; Sweet S; Kassaye S; Ssali C
    Adv Dent Res; 2006 Apr; 19(1):152-7. PubMed ID: 16672566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
    Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AIDS. HIV antibodies detected in saliva].
    Fortschr Med; 1989 Feb; 107(4):77. PubMed ID: 2925144
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral transmission of HIV.
    Rothenberg RB; Scarlett M; del Rio C; Reznik D; O'Daniels C
    AIDS; 1998 Nov; 12(16):2095-105. PubMed ID: 9833850
    [No Abstract]   [Full Text] [Related]  

  • 18. The anti-HIV-1 activity associated with saliva.
    Shine N; Konopka K; Düzgüneş N
    J Dent Res; 1997 Feb; 76(2):634-40. PubMed ID: 9062556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
    Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
    Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
    J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.